Kenneth S. Ramos

发表

Pricing methods in outcome-based contracting: integration analysis of the six dimensions (6 δs)

B. Erstad, M. Slack, I. Abraham, 2020, Journal of medical economics.

Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure

B. Erstad, J. Karnes, M. Slack, 2020, American Journal of Cardiovascular Drugs.

Ex ante economic evaluation of genetic testing for the ARG389 beta1-adrenergic receptor polymorphism to support bucindolol treatment decisions in Stage III/IV heart failure

B. Erstad, J. Karnes, M. Slack, 2018, Expert Review of Precision Medicine and Drug Development.

Pricing methods in outcome-based contracting: δ2: willingness-to-pay-based pricing

B. Erstad, M. Slack, I. Abraham, 2020, Journal of medical economics.

Pricing methods in outcome-based contracting: δ3: reference-based pricing

B. Erstad, M. Slack, I. Abraham, 2020 .

Pricing methods in outcome-based contracting: δ1: cost effectiveness analysis and cost-utility analysis-based pricing

B. Erstad, M. Slack, I. Abraham, 2020, Journal of medical economics.

Pricing methods in outcome-based contracting: δ5: risk of efficacy failure-based pricing

B. Erstad, D. Billheimer, M. Slack, 2020, Journal of medical economics.

Pricing methods in outcome-based contracting: δ4: safety-based pricing

B. Erstad, M. Slack, I. Abraham, 2020, Journal of medical economics.

Pricing methods in outcome-based contracting: δ6: adherence-based pricing

B. Erstad, M. Slack, I. Abraham, 2020, Journal of medical economics.

Implementation of Pharmacogenomics and Artificial Intelligence Tools for Chronic Disease Management in Primary Care Setting

G. Udeani, Patrick Silva, Asim Abu-Baker, 2021, Journal of personalized medicine.

Pricing methods in outcome-based contracting: δ3: reference-based pricing

B. Erstad, M. Slack, I. Abraham, 2020, Journal of medical economics.